Feline Upper Respiratory Infections: Etiology, Transmission, and Zoonotic Potential

Feline upper respiratory infections (URIs) represent a multifactorial disease complex that is among the most common reasons for veterinary consultation in cats worldwide [1]. The syndrome is primarily caused by a combination of viral and bacterial pathogens that target the nasal passages, oropharynx, conjunctiva, and trachea [2]. Understanding the etiological agents, transmission pathways, and zoonotic potential of these pathogens is essential for effective diagnosis, treatment, and public health risk communication.

Etiology

Viral Pathogens

Two viruses account for the majority of feline URI cases: feline herpesvirus type 1 (FHV-1) and feline calicivirus (FCV) [1, 2]. FHV-1 is an enveloped double-stranded DNA virus of the family Herpesviridae that establishes lifelong latency in the trigeminal ganglia after primary infection [2]. Reactivation occurs during periods of stress, leading to intermittent viral shedding and clinical recrudescence [2]. FCV is a non-enveloped single-stranded RNA virus of the family Caliciviridae that exhibits high antigenic variability, resulting in multiple strains with varying virulence [3]. Feline respiratory infections of viral origin are rarely associated with direct zoonotic transmission, as FHV-1 and FCV are highly host-specific and do not replicate in human tissues [2].

Bacterial Pathogens

While primary bacterial infections are less common, two bacterial species frequently act as primary or secondary invaders in feline URI: Bordetella bronchiseptica and Chlamydia felis [2, 3]. Bordetella bronchiseptica is a Gram-negative coccobacillus that adheres to ciliated respiratory epithelium via filamentous hemagglutinin and pertactin adhesins [2]. It is an important component of the feline respiratory disease complex and can also infect dogs, pigs, and occasionally humans [1]. Chlamydia felis is an obligate intracellular Gram-negative bacterium that primarily causes conjunctivitis, though it can also contribute to rhinitis [2, 3]. Mycoplasma felis and Mycoplasma gatae are also isolated from cats with URI, though their primary pathogenic role remains debated [2]. Secondary bacterial infections with opportunistic commensals such as Pasteurella multocida, Streptococcus spp., and Escherichia coli may complicate viral URI [3].

How Do Cats Get Respiratory Infections?

Transmission of feline URI pathogens occurs predominantly via direct contact with infected animals or contaminated fomites [1, 2]. FHV-1 and FCV are shed in high concentrations in ocular, nasal, and oral secretions [2]. Cats acquire infection through inhalation of aerosolized droplets, direct nose-to-nose contact, or contact with contaminated objects such as food bowls, bedding, and grooming tools [3]. Bordetella bronchiseptica is also transmitted via aerosol and direct contact, and transmission can occur between cats and dogs in the same household [1, 2]. Chlamydia felis is primarily transmitted through direct contact with infected ocular secretions, and transmission via fomites is less efficient [2]. Stressors such as crowding, poor ventilation, concurrent disease, and immunosuppression increase the risk of transmission and clinical expression of disease [3].

Clinical Signs and Assessment of Disease Severity

Are cat respiratory infections dangerous? The majority of feline URIs are self-limiting in immunocompetent adult cats, but infections can become severe or fatal in kittens, geriatric cats, and immunocompromised individuals [2, 3]. Clinical signs typically include sneezing, serous to mucopurulent nasal discharge, conjunctival hyperemia, chemosis, ocular discharge, and occasional corneal ulceration (FHV-1) [1]. FCV often presents with oral ulcers on the tongue, hard palate, and lips, along with hypersalivation and pyrexia [2]. Virulent systemic strains of FCV can cause severe pneumonia, edema, and high mortality [3]. Bordetella bronchiseptica infection is characterized by a paroxysmal cough that mimics kennel cough in dogs, and can progress to bronchopneumonia in kittens [1]. Chlamydia felis typically produces bilateral conjunctivitis with prominent chemosis and serous or mucoid ocular discharge; rhinitis and lower respiratory signs are uncommon [2]. Untreated secondary bacterial infections, dehydration, and anorexia can lead to significant morbidity, making early intervention important in high-risk populations [3].

Diagnostic Approach

Diagnosis of feline URI relies on clinical history, physical examination, and confirmatory laboratory testing [1, 2]. Oropharyngeal, conjunctival, and nasal swabs are commonly submitted for polymerase chain reaction (PCR) assays that can simultaneously detect FHV-1, FCV, Bordetella bronchiseptica, Chlamydia felis, and Mycoplasma spp. [3]. Quantitative PCR (qPCR) may be used to estimate viral loads, though detection does not differentiate active infection from latency or recent vaccination [2]. Bacterial culture and antimicrobial susceptibility testing are indicated when Bordetella infection is suspected or when empirical therapy has failed [1]. Serological testing is of limited utility for acute diagnosis because of high seroprevalence in the population [2]. Imaging (radiography or computed tomography) may help identify concurrent bronchopneumonia or chronic rhinosinusitis [3].

flowchart TD
    A[Cat presents with sneezing, nasal discharge, conjunctivitis], > B{Clinical assessment}
    B, > C[Oral ulcers present?]
    C, Yes, > D[Suspect FCV]
    C, No, > E[Corneal ulcers or dendritic lesions?]
    E, Yes, > F[Suspect FHV-1]
    E, No, > G[Cough dominant?]
    G, Yes, > H[Suspect Bordetella]
    G, No, > I[Conjunctivitis with chemosis dominant?]
    I, Yes, > J[Suspect Chlamydia]
    I, No, > K[Collect swab for PCR panel]
    D, > K
    F, > K
    H, > K
    J, > K
    K, > L[PCR results guide therapy]

Treatment and Management

Therapeutic strategies for feline URI are directed at the specific etiology and include supportive care, antiviral or antibiotic agents, and management of secondary infections [1, 2]. For FHV-1, topical ophthalmic cidofovir or oral famciclovir (in cats) can reduce viral shedding and clinical severity [2]. FCV infections are treated supportively, as no specific antiviral is approved; interferon‑omega may be used adjunctively [3]. Bacterial infections require species‑appropriate antimicrobial therapy. Doxycycline is the drug of choice for Chlamydia felis and Mycoplasma spp., and is also effective against Bordetella bronchiseptica, though some isolates show resistance to tetracyclines [1, 2]. Pradofloxacin may be considered for refractory Bordetella infections [3]. Supportive measures include humidification, enteral nutrition via feeding tubes, fluid therapy, and removal of ocular and nasal discharges [2]. Vaccination against FHV-1, FCV, and Chlamydia felis is available and recommended as a core vaccine for all cats, though it does not provide sterilizing immunity [1]. Minimizing stress and providing good ventilation and hygiene in multi‑cat environments reduces transmission risk [3].

Zoonotic Potential

Is cat respiratory infection contagious to humans? Among the common feline URI pathogens, only Bordetella bronchiseptica has established zoonotic potential, and transmission to humans is rare [1, 2]. In immunocompetent individuals, Bordetella bronchiseptica infection may cause a mild pertussis‑like illness, but severe respiratory disease has been reported in immunocompromised patients (e.g., HIV/AIDS, organ transplant recipients) [2]. Direct transmission from cats to humans is documented through close contact with respiratory secretions [1]. Chlamydia felis has been reported to cause conjunctivitis in humans after exposure to ocular secretions from an infected cat, but this is extremely uncommon [2, 3]. FHV-1 and FCV are not known to infect humans [1, 2]. Veterinary professionals and owners of cats with respiratory signs should practice basic hygiene: handwashing after handling, avoiding direct contact with ocular and nasal discharges, and wearing gloves when administering eye medications [3]. Immunosuppressed individuals should be advised to minimize contact with cats showing active respiratory signs [2].

Prevention and Public Health Considerations

Prevention of feline URI centers on vaccination, biosecurity, and stress reduction [1]. Core vaccines containing modified‑live or inactivated FHV-1 and FCV are administered to kittens starting at 6–8 weeks of age, with boosters according to current feline vaccination guidelines [2]. Chlamydia felis vaccines are available but considered non‑core, typically recommended for catteries or multi‑cat environments [3]. Bordetella vaccines are available for use in high‑risk shelter and cattery populations [1]. In shelter settings, early detection and isolation of affected animals, use of disinfectants effective against non‑enveloped viruses (e.g., accelerated hydrogen peroxide or chlorine‑based products for FCV), and provision of adequate ventilation are critical to outbreak control [2, 3]. Given the low zoonotic risk, feline URI should not be a cause for alarm in healthy human populations, but awareness of potential transmission in immunocompromised individuals is warranted [1, 2].

Conclusion

Feline upper respiratory infections are a common, often multifactorial disease complex caused primarily by FHV-1, FCV, Bordetella bronchiseptica, and Chlamydia felis. Understanding the unique biophysical properties and transmission mechanisms of each pathogen is essential for accurate diagnosis, appropriate antimicrobial stewardship, and effective outbreak management. While the zoonotic risk is very low, Bordetella bronchiseptica and Chlamydia felis can rarely cause disease in humans, emphasizing the need for infection control precautions in vulnerable populations.

References

[1] Merck Veterinary Manual. Feline Respiratory Disease Complex. Kenilworth, NJ: Merck & Co.; updated regularly. Accessed via merckvetmanual.com.

[2] Greene CE. Infectious Diseases of the Dog and Cat. 4th ed. St. Louis, MO: Elsevier Saunders; 2012.

[3] Sykes JE. Canine and Feline Infectious Diseases. St. Louis, MO: Elsevier Saunders; 2014. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.